• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in
COVID-19: Which vaccines are people getting?

COVID-19: Which vaccines are people getting?

by Truveta Research | Feb 3, 2022 | Research, Research Insights

As we shared in our latest Truveta Platform insights last week, the COVID-19 Omicron variant has highlighted the positive impact of vaccinations and boosters in preventing hospitalization. Thus, we wanted to shed light on the percentage of people who are fully...
Percent of COVID-19 hospitalizations decreasing

Percent of COVID-19 hospitalizations decreasing

by Truveta Research | Jan 28, 2022 | Research, Research Insights

Just last week marked the two-year anniversary of the first case of COVID-19 in the United States, discovered by our health system member Providence. It’s hard to believe that it’s been two years, and just this past month we’ve experienced the highest number of daily...
Next Entries »

Share this


Recent posts

  • Real-world analysis links Dexcom CGM use to reduced progression of chronic kidney disease
  • Truveta experts: Gestational diabetes screening in real-world practice
  • Non-small cell lung cancer: Biomarkers, treatments, and outcomes in real-world data

Follow Truveta


Sign up for our newsletter

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Solutions

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2025

Our website uses cookies to ensure you have the best experience.